Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
38.85
-0.95 (-2.39%)
May 2, 2025, 11:58 AM CST
Great Novel Therapeutics Biotech & Medicals Company Description
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers.
It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors.
The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Great Novel Therapeutics Biotech & Medicals
Country | Taiwan |
Founded | 2013 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 18 |
CEO | Chia-Nan Chen |
Contact Details
Address: No.508, Zhongxiao East Road Taipei City, 115 Taiwan | |
Phone | 886 2 2785 1399 |
Website | gntbm.com.tw |
Stock Details
Ticker Symbol | 7427 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0007427007 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Chia-Nan Chen | Chief Executive Officer |